Accuray is the premier radiation oncology company that develops, manufactures and sells personalized innovative treatment solutions that set the standard of care, with the aim of helping patients live longer, better lives. The Company’s leading-edge technologies – the CyberKnife and TomoTherapy Systems – are designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy and adaptive radiation therapy.

Our Vision:

A future where the fear, pain and suffering of cancer are a thing of the past.

Our Mission:

To develop personalized, leading-edge treatment solutions that help cancer patients live longer, better lives.

Why - What We Do - is Important:

• To patients – Accuray offers new hope to cancer patients through innovations that help them live longer, better lives.
• To customers – Accuray’s leading-edge treatment solutions expand clinical opportunities for healthcare providers, helping them offer the best treatment for each patient.
• To investors – Accuray offers unique & well-differentiated products specifically designed for image-guided radiosurgery and IMRT; two rapidly growing market segments.
• To colleagues – Accuray colleagues are committed to fundamentally changing the future of cancer treatment and helping patients live longer, better lives.